Ubon Bio Ethanol PCL
Ubon Bio Ethanol PCL produces and distributes bioethanol and related products, primarily serving the energy and transportation sectors in Thailand.
Business. Ubon Bio Ethanol PCL (UBE.BK) is an energy company engaged in oil and gas refining and marketing activities. The firm is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Ubon Bio Ethanol PCL (UBE.BK) is an energy company engaged in oil and gas refining and marketing activities. The firm is headquartered in Thailand and is primarily listed on the Stock Exchange of Thailand. Specific details regarding its operating segments and geographic revenue mix are not available.
Ubon Bio Ethanol maintains a debt-to-equity ratio of 0.44, indicating a relatively conservative capital structure compared to the industry median of 0.65. The company's liquidity position is assessed as medium, with a current ratio of 1.39 and negative net cash after subtracting total debt. Free cash flow of 170.7 million THB in the latest period suggests some capacity to fund operations or reduce debt, though operating cash flow was negative at -1.46 billion THB.
Profitability metrics show a return on equity of 1.84% and a return on assets of 1.19%, both below the industry median of 3.2% and 2.8%, respectively. Gross profit of 286.5 million THB and operating income of 133.3 million THB reflect modest margins in a competitive refining and marketing environment. The company's net income of 107.6 million THB is supported by cost controls but remains constrained by input price volatility.
The company's revenue is concentrated in Thailand, with no disclosed international operations. Segment data is not available, but the single-product focus on bioethanol exposes the company to regulatory and feedstock price risks. The lack of geographic diversification increases vulnerability to local economic and policy shifts.
Revenue growth is expected to remain flat in the current fiscal year, with a projected decline of 2.1% in the next fiscal year. This outlook is driven by saturated domestic demand and limited export opportunities. Capital expenditure of -37.2 million THB in the latest period suggests minimal investment in expansion, aligning with the company's current strategy of operational efficiency.
Risk factors include liquidity constraints and exposure to volatile feedstock prices. The company's liquidity risk is moderate, but the negative operating cash flow raises concerns about short-term solvency. Dilution risk is assessed as low, with no near-term pressure from share issuance or convertible debt. However, the company's reliance on debt financing could increase leverage if operating performance deteriorates.
Recent filings and transcripts highlight the company's focus on cost optimization and compliance with environmental regulations. No material events have been disclosed in the past quarter that would significantly alter the company's strategic direction or financial position.
- Ubon Bio Ethanol maintains a conservative capital structure with a debt-to-equity ratio of 0.44.
- Profitability metrics are below industry medians, with a return on equity of 1.84% and return on assets of 1.19%.
- Revenue is concentrated in Thailand, with no international diversification.
- Growth is expected to be flat in the current fiscal year, with a projected decline in the next fiscal year.
- Liquidity risk is moderate, but negative operating cash flow raises concerns about short-term solvency.
- Dilution risk is low, with no near-term pressure from share issuance or convertible debt.
Bull / Bear case
Generated · model-assistedDebt-to-equity ratio of 0.44 is below the 0.36 cohort median, suggesting a conservative leverage profile.
Free cash flow turned positive to 168 million THB in the latest period, reversing prior negative trends.
Dilution risk is assessed as low, providing stability for existing shareholders' equity interests.
Net income plummeted 140.8% year-over-year to a loss of 103 million THB, eroding profitability.
Credit risk is flagged as high, posing potential challenges for debt servicing and financial stability.
Cash conversion ratio of -13.59 places the company in the bottom quartile of its peer cohort.
In focus — financials by report
Revenue THB 7.20B, +3,2% YoY; Operating income −32,0% YoY.
- ▍Revenue THB 7.20B, +3,2% YoY
- ▍Operating income −32,0% YoY
- ▍Net income +2,6% YoY
- ▍Free cash flow +42,8% YoY
- ▍Net margin 4.6%
Revenue THB 6.97B; Operating income THB 453.3M.
- ▍Revenue THB 6.97B
- ▍Operating income THB 453.3M
- ▍Net margin 4.6%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Ubon Bio Ethanol PCL Market data — financials · 2026-05-29
Ownership & reference
Leadership
- Somkeirt HudthagosolExecutive Chairman of the Board